![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Janssen Pharmaceutica Nv Beerse Be, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Loperamide hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R2-CEP 1994-020 - Rev 05
This Chemical Type CEP, issued on November 19, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 929 associated with this CEP further emphasizes